MedTrace Logo

Platelet Rich Plasma Injection Into Ovary of Patients With Premature Ovarian Insufficiency

NCT04149028 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2023-02-17

No results posted yet for this study

Summary

All encountered cases with POI will be assessed and examined then investigated. Eligible cases will be included in the study

Conditions

  • Premature Ovarian Failure

Interventions

PROCEDURE

PRP injection inside the ovary by laparoscoy. The injection volume is 2 ml

intraovarian injection of 2 mml of PRP by laparoscopic guide

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04149028 on ClinicalTrials.gov